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background: Acute coronary syndrome and anticoagulation in patients with idiopathic thrombocytopenic purpura (ITP) is a complex therapeutic 
challenge. There are limited data on the safety and efficacy of treatment options.
case:  A 72-year-old former smoker with a history of hypertension, chronic demyelinating polyneuropathy and ITP (platelet count 15x109 /L) on 
chronic steroid therapy presented with resting shortness of breath for 4 days and signs of Killip III heart failure. EKG revealed ST segment depression 
in leads V4 to V6 and Q wave in lead III with depressed left ventricular (LV) function (ejection fraction of 35%), generalized wall thinning, and apical 
thrombus. Coronary angiogram revealed chronic total occlusion of mid right coronary artery, 90% stenosis of mid left circumflex and mid left anterior 
descending arteries (LAD). He was frail on examination with severe generalized bruises and mucosal bloody oozing and was turned down for cardiac 
surgery due to concerns for wound healing and ability to tolerate surgery. Hematology team recommended 5 cycles of intravenous immunoglobulin, 
random donor apheresis before any procedure.
Decision-making:  There was initial reluctance of the surgical and interventional team to proceed with revascularization due to this high risk 
nature of anticoagulation and concern for lack of viable myocardium. Cardiac MRI showed > 99% of the myocardium. After a detailed discussion 
of risks of intervention successful angioplasty and bare-metal stenting was performed to the mid-LAD and mid-left circumflex extending into the 
proximal obtuse marginal. He was placed on aspirin 81 mg, clopidogrel 75 mg and warfarin for initial 2 weeks followed by aspirin and warfarin. Post 
procedure course was complicated by one episode of epistaxis. At one-month and one year he was asymptomatic without any episodes of angina 
with recovery of LV function and resolution of the thrombus.
conclusion: This case demonstrates the delicate challenge of anti-platelet and anti-coagulation treatments in patients with ITP in the setting of 
myocardial infarction and LV thrombus. It also demonstrates the utility of multimodality imaging to guide interventional therapy in high risk patients.
